Oleuropein as a novel anti-diabetic nutraceutical. An overview

Journal Title: Archives of Diabetes & Obesity - Year 2018, Vol 1, Issue 3

Abstract

Among the cardiometabolic diseases, type 2 diabetes mellitus (T2DM) is one of the most diffused worldwide. Pharmacological treatments commonly used present several side effects, and this is driving people to search natural approaches. Olea europaea is currently investigated for its anti-diabetic potential. In particular, oleuropein (OLE), its main bioactive compound, have been demonstrated to exert interesting activities in management of T2DM, including hypoglycemic and antioxidant activities. The purpose of this manuscript is to review the available scientific evidence evaluating the role of OLE in managing T2DM. Among the cardiometabolic disease, type 2 Diabetes Mellitus (T2DM) is greatly diffused in the World, affecting several million people. In last few years, indeed, T2DM was considered as an epidemic [1]. At the base of the T2DM a etiology there is a reduction in β-cells function and/or the presence of insulin-resistance (IR), causing chronically elevated glycemic levels [2,3]. Chronic hyperglycemia, in turn, is one of the main causes of oxidative stress, which is recognized to be the principal responsible for T2DM complications [4-7].

Authors and Affiliations

Giuseppe Annunziata, Maria Maisto, Connie Schisano, Luigi Barrea, Roberto Ciampaglia, Viviana Narciso, Gian Carlo Tenore, Ettore Novellino

Keywords

Related Articles

Type 2 Diabetes and Hypertension among Saudi Patients with Obesity

Background and Objective: Obesity is a major risk factor for non communicable diseases. Obesity, diabetes and hypertension are so tightly linked. This study aims to determine the frequency of type 2 diabetes and hyperten...

Prevalence of Obesity and Association with Adherence to Mediterranean Diet in Medical, Nursing and Administrative Staff of a Greek Public Hospital

Obesity is currently considered to be the most common metabolic disease. During the last decades, its incidence has dramatically risen both in developed and developing countries. Several studies of the health of healthca...

A Phase II Study to Evaluate Connections in Higher Risk For Heart Disease and Narcissists Appearance in Private Pharmacy Institutions Pune University India Behaviors Among Men Who Have Work With Men (MM): Is There Evidence of an Effect?

Respect can earn. Wrinkle shows life is loved your life and ageing with dignity. Self-admiration increasing day by day. According to a study conducted by the Private Pharmacy Instituions in Pune University, men women hav...

Evaluation of the Prevalence of Gestational Diabetes Using Fasting Blood Glucose and Glycated Heamoglobin in Yenagoa Metropolis

There is understanding that most pregnant women with gestational diabetes mellitus stands the risk of having adverse obstetric and perinatal outcome. The need for an early detection and effective management of this probl...

Resveratrol-based Nutraceuticals for the Management of Diabetes and Obesity: Real Therapeutic Potential or a mere Palliative?

It is well known that obesity and diabetes (more specifically, the type 2 diabetes mellitus, T2DM) are currently a growing public health problem, which involves several millions subjects in the World. Years ago, indeed,...

Download PDF file
  • EP ID EP588763
  • DOI 10.32474/ADO.2018.01.000113
  • Views 78
  • Downloads 0

How To Cite

Giuseppe Annunziata, Maria Maisto, Connie Schisano, Luigi Barrea, Roberto Ciampaglia, Viviana Narciso, Gian Carlo Tenore, Ettore Novellino (2018). Oleuropein as a novel anti-diabetic nutraceutical. An overview. Archives of Diabetes & Obesity, 1(3), 54-58. https://europub.co.uk/articles/-A-588763